Literature DB >> 11550971

Hospital admissions, length of stay, charges, and in-hospital death among patients with systemic sclerosis.

P J Nietert1, M D Silverstein, R M Silver.   

Abstract

OBJECTIVE: To investigate population hospitalization rates to community hospitals for systemic sclerosis (SSc, scleroderma) and examine whether age, sex, race, and insurance status independently predict length of stay (LOS), hospital charges, and in-hospital death.
METHODS: The 1995 Healthcare Cost and Utilization Project national inpatient sample was used to identify 3,621 SSc hospitalizations. Weighted age, sex, and race-specific frequencies were divided by population estimates to calculate hospitalizations per million people. Regression models were used to model LOS, charges, and in-hospital death with age, sex, race, and insurance serving as the primary independent variables. Covariates included numbers of diagnoses and procedures, whether or not the admission was a transfer from another hospital, and the presence of comorbid conditions.
RESULTS: Population hospitalization rates were higher for non-whites compared to whites among those < 65, while rates were higher for whites compared to non-whites for those > or =65 years old. On average, non-whites were at least 10 years younger than whites. The mean LOS was 7.5 days, with whites' average LOS being 10% shorter than non-whites', and patients with public health insurance having approximately 9% longer LOS than those with private insurance. Charges averaged almost US$15,000 per hospitalization (median = $8,441), amounting to $280 million in community hospital charges in the U.S. in 1995. The overall in-hospital death rate was 7.1%.
CONCLUSION: These patterns are consistent with a greater burden and increased severity of disease among non-whites under age 65 with Ssc.

Entities:  

Mesh:

Year:  2001        PMID: 11550971

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  15 in total

1.  Automated Measurement of Microvascular Function Reveals Dysfunction in Systemic Sclerosis: A Cross-sectional Study.

Authors:  Daniel R Machin; Phillip E Gates; Hans Vink; Tracy M Frech; Anthony J Donato
Journal:  J Rheumatol       Date:  2017-09-15       Impact factor: 4.666

2.  Frequency, cost, and risk factors of readmissions among severe sepsis survivors.

Authors:  Andrew J Goodwin; David A Rice; Kit N Simpson; Dee W Ford
Journal:  Crit Care Med       Date:  2015-04       Impact factor: 7.598

3.  Systemic sclerosis mortality in the United States: 1979-1998.

Authors:  Eswar Krishnan; Daniel E Furst
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

4.  Trends in utilization of adrenalectomy in the United States: have indications changed?

Authors:  Brian D Saunders; Reid M Wainess; Justin B Dimick; Gilbert R Upchurch; Gerard M Doherty; Paul G Gauger
Journal:  World J Surg       Date:  2004-11       Impact factor: 3.352

5.  Exercise-induced brachial artery blood flow and vascular function is impaired in systemic sclerosis.

Authors:  Daniel R Machin; Heather L Clifton; Ryan S Garten; Jayson R Gifford; Russell S Richardson; D Walter Wray; Tracy M Frech; Anthony J Donato
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-09-30       Impact factor: 4.733

6.  Ethnic disparities among patients with systemic lupus erythematosus in South Carolina.

Authors:  Erica Anderson; Paul J Nietert; Diane L Kamen; Gary S Gilkeson
Journal:  J Rheumatol       Date:  2008-03-15       Impact factor: 4.666

Review 7.  Determinants of mortality in systemic sclerosis: a focused review.

Authors:  Dilli Ram Poudel; Divya Jayakumar; Abhijeet Danve; Shiv Tej Sehra; Chris T Derk
Journal:  Rheumatol Int       Date:  2017-11-07       Impact factor: 2.631

8.  Health-care utilization in Dutch systemic sclerosis patients.

Authors:  Jessica Meijs; Elisabeth J M Zirkzee; Anne A Schouffoer; Stella M Henquet; Monique A A Caljouw; Theo Stijnen; Tom W J Huizinga; Annemie J M Schuerwegh; Theodora P M Vliet Vlieland
Journal:  Clin Rheumatol       Date:  2013-08-28       Impact factor: 2.980

9.  Patients' length of stay in women hospital and its associated clinical and non-clinical factors, tehran, iran.

Authors:  R Ravangard; M Arab; H Zeraati; A Rashidian; A Akbarisari; F Mostaan
Journal:  Iran Red Crescent Med J       Date:  2011-05-01       Impact factor: 0.611

Review 10.  Ethnicity and race and systemic sclerosis: how it affects susceptibility, severity, antibody genetics, and clinical manifestations.

Authors:  John D Reveille
Journal:  Curr Rheumatol Rep       Date:  2003-04       Impact factor: 4.686

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.